Search

Your search keyword '"D'Amato, Maria"' showing total 113 results

Search Constraints

Start Over You searched for: Author "D'Amato, Maria" Remove constraint Author: "D'Amato, Maria" Publisher elsevier bv Remove constraint Publisher: elsevier bv
113 results on '"D'Amato, Maria"'

Search Results

1. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

4. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

5. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

7. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach

9. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

11. Family planning considerations in people with multiple sclerosis

12. Genetic heritage of the Baphuthi highlights an over-ethnicized notion of “Bushman” in the Maloti-Drakensberg, southern Africa

13. Multiple sclerosis progression: time for a new mechanism-driven framework

16. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions

18. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists

19. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

20. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis

21. Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic

23. Progression independent of relapse activity in early multiple sclerosis patients

24. Long-term disability progression in childhood and adolescent onset multiple sclerosis patients

25. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEQ-IT)

26. Comparative effectiveness of early intensive or escalation treatment strategies on long term disability trajectories in relapsing multiple sclerosis patients

27. Myelin-oligodendrocyte glycoprotein antibody-associated disease

28. Predicting haplogroups using a versatile machine learning program (PredYMaLe) on a new mutationally balanced 32 Y-STR multiplex (CombYplex) : Unlocking the full potential of the human STR mutation rate spectrum to estimate forensic parameters

31. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

33. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis

34. Predicting haplogroups using a versatile machine learning program (PredYMaLe) on a new mutationally balanced 32 Y-STR multiplex (CombYplex): Unlocking the full potential of the human STR mutation rate spectrum to estimate forensic parameters

35. DNA commission of the International Society of Forensic Genetics (ISFG): Recommendations on the interpretation of Y-STR results in forensic analysis

36. A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients

37. hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients

44. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

45. The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study

47. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

Catalog

Books, media, physical & digital resources